tizanidine hydrochloride tizanidine hydrochloride capsule
1 INDICATIONS AND USAGE Tizanidine hydrochloride capsules are central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine hydrochloride capsules should be reserved for those daily activities and times when relief of spasticity is most important [see Dosage and Administration (2.1) ] . Tizanidine hydrochloride capsules are central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine hydrochloride capsules should be reserved for those daily activities and times when relief of spasticity is most important. (1)
jubilant cadista pharmaceuticals inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 Tizanidine Hydrochloride capsules Tizanidine hydrochloride capsules are available in three strengths as two-piece hard gelatin capsules containing tizanidine hydrochloride USP 2.29 mg, 4.58 mg and 6.87 mg, equivalent to 2 mg, 4 mg and 6 mg tizanidine base. Tizanidine Hydrochloride capsules are supplied as: 2 mg: The capsules have blue opaque cap and white opaque body, size ā4ā hard gelatin, printed radially in black ink with āCā on the cap and ā670ā on the body. Bottle of 30ās (child-resistant) NDC 59746-670-30 Bottle of 100ās (child-resistant) NDC 59746-670-01 Bottle of 150ās (child-resistant) NDC 59746-670-34 Bottle of 1000ās (ribbed-stock) NDC 59746-670-10 4 mg: The capsules have light blue opaque cap and body, size ā3ā hard gelatin, printed radially in black ink with āCā on the cap and ā671ā on the body. Bottle of 30ās (child-resistant) NDC 59746-671-30 Bottle of 100ās (child-resistant) NDC 59746-671-01 Bottle of 150ās (child-resistant) NDC 59746-671-34 Bottle of 1000ās (ribbed-stock) NDC 59746-671-10 6 mg: The capsules have light blue opaque cap and white opaque body, size ā2ā hard gelatin, printed radially in black ink with āCā on the cap and ā672ā on the body. Bottle of 30ās (child-resistant) NDC 59746-672-30 Bottle of 100ās (child-resistant) NDC 59746-672-01 Bottle of 150ās (child-resistant) NDC 59746-672-34 Bottle of 500ās (ribbed-stock) NDC 59746-672-05 Store at 20Ā° to 25Ā°C (68Ā° to 77Ā°F); excursions permitted to 15Ā° to 30Ā°C (59Ā° to 86Ā°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container [see USP]. Dispense in containers with child resistant closure.
More pills like CAPSULE C 671